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Background: Post-hospital syndrome refers to the period of generalized risk of adverse health outcomes among
patients who are recently discharged from hospital. This period is associated with a short-term increased risk of
readmission which may not be related to the original condition. While the majority of studies of post-hospital
syndrome have focused on all-cause readmissions, whether and to what extent such a phenomenon exists within
discrete medical conditions is not yet known.
Objective: To investigate whether the risk of admission due to asthma is increased in individuals who are
discharged following any-cause hospital admission.
Methods: Using administrative health data for the period 1997 to 2007 from the province of British Columbia, Canada,
we created a cohort of adults with asthma. Using a case-crossover design, we assessed the association between discharge
from a hospital (exposure) within 30 days before an asthma-related hospitalization (the outcome), using two 30-day
control periods within the same subject. Conditional logistic regression was performed to calculate the relative risk (RR)
of the outcome in association with exposure. We performed several sensitivity and subgroup analyses.
Results: The final cohort included 3,852 patients experiencing 6,333 instances of the outcome. Mean age at the time of
the outcome was 43.7 (SD 14.2), 69.0% of such outcomes belonged to females. The RR of the outcome within the next
30 days of a previous any-cause discharge was 1.40 (95% CI 1.22 - 1.59). However, the association was mainly caused by
discharge from asthma-related admission [RR = 1.99 (95% CI 1.65 - 2.39)]. The RR associated with non-asthma-related
discharge was 0.88 (95% CI 0.74 - 1.04) and was not statistically significant. Similar results were obtained in a
range of sensitivity analyses.
Discussion: Our results indicate that in patients with asthma, the 30-day risk of asthma-related admission is increased
after an episode of asthma-related hospitalization, but not after an episode of non-asthma-related hospitalization.Introduction
Post-hospital syndrome refers to the acquired, transient
period of generalized increased risk for a broad range of
health conditions after discharge from hospital [1]. An
important manifestation of this syndrome is the high
rate of readmission in the critical 30 days after discharge,
which is not necessarily due to the same condition. A
recent study showed that nearly 20% of patients covered
by a US national insurance program (Medicare, consisting* Correspondence: msafavi@mail.ubc.ca
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article, unless otherwise stated.of individuals aged 65 and older as well as those with
disabilities or end stage renal disease) discharged from
a hospital had another acute medical problem within the
subsequent 30 days that necessitated re-hospitalization
[2]. Reasons for readmissions often include heart failure,
pneumonia, COPD, infection, gastrointestinal conditions,
mental illness, metabolic derangements, and trauma
[2]. Various etiological reasons are postulated for this
phenomenon, including disturbances of sleep, nutri-
tional issues, pain and discomfort, and psychological
confusion [1].
While the typical post-hospital syndrome affects
mostly elderly patients with co-morbid conditions, the
potential etiologic factors exist regardless of age. In
addition, potential causal factors might have differential
effects across different medical conditions. As such,tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Sadatsafavi et al. Allergy, Asthma & Clinical Immunology 2013, 9:49 Page 2 of 8
http://www.aacijournal.com/content/9/1/49studying post-hospital syndrome within the realm of spe-
cific diseases can be informative from a patho-physiological
perspective, and is also important from a clinical perspec-
tive as it can help risk-stratify individuals at the time of
discharge from hospital.
To our knowledge, no previous study has examined
the risk of an asthma-related hospitalization after discharge
from a previous hospitalization. Any hospitalization inde-
pendent of the cause might affect the risk of a subsequent
asthma exacerbation in complex ways. Some of the postu-
lated factors for the post-hospital syndrome can increase
the risk of worsening of asthma symptoms and asthma
exacerbations. For example, psychological stress is known
to be associated with asthma attacks [3], and changes in
the immune system and malnutrition are all associated
with an increased risk of the worsening of asthma [4].
In addition, medications that patients receive during
admission (e.g., non-steroidal anti-inflammatory drugs or
beta-blockers) might cause drug-induced exacerbations
[5]. On the other hand, patients with asthma who are
hospitalized for other reasons will most likely also be
managed for their asthma during the inpatient period,
and at times receive potent anti-inflammatory medications
which can reduce the risk of an asthma attack. Combining
all these factors, there seems to be different potential
mechanisms for post-hospital syndrome affecting the
risk of an asthma-related admission that has not hitherto
been evaluated.
Using administrative health data from the province
of British Columbia, Canada, we set out to evaluate
whether individuals with asthma are at higher risk of an
episode of asthma-related hospitalization after discharge
from hospitalization due to any cause. We also evaluated
such a risk across different subgroups of patients, and
evaluated the risk according to the cause of the original




Records of the utilization of all billed services for the
fiscal years 1997 to 2007 were obtained from the British
Columbia Ministry of Health (http://www.popdata.bc.
ca/data) [6]. This study was approved by University of
British Columbia-Providence Health Care Research Ethics
Board (#H08-01287). No consent was required as the
data consisted of anonymized health records released to
investigators in accordance with the Provincial Freedom
of Information and Protection of Privacy Act. We had
access to consolidation files [7] and all records of inpatient
[8] and outpatient [9] encounters, as well as medication
dispensations (the PharmaNET database [10]) during this
period. Hospitalization and outpatient service use records
contain encounter dates and International Classification ofDiseases (ICD, 9th and 10th revisions) codes for the reason
for the encounter. For hospitalization records, up to 25
ICD codes are recorded, one of which is designated as the
‘most responsible’ diagnosis; i.e., the diagnosis responsible
for the greatest portion of the patient’s stay in the hospital.
The length of stay in the hospital as well as admission type
(urgent versus elective) is also available. The medication
dispensation database includes variables such as the
unique drug identifier and date of dispensation [11].
Study cohort
Adults (age 18 years and older) were considered as having
asthma if during a rolling time window of 12 months they
filled prescriptions for at least three asthma-related medi-
cations (list of such medications is available in Additional
file 1). The date of the first of the three prescriptions was
considered the cohort entry date. The date of the last
resource use of any type was considered the exit date.
Design
We chose a case-crossover design for this study in which
each individual subject acts as their own control [12]. In
the study of the association of transient exposures with
acute outcomes, such as this study, the case-crossover
design is an attractive option as it inherently removes the
potential biasing effects of unmeasured, time-invariant
confounding factors [13]. Adjusting for such unmeasured
confounding factors is particularly important in the
present context as both the exposure and outcome in this
study are hospitalization events, and many factors might
affect the overall person-specific rate of hospitalization
(e.g., the patient’s and care provider’s threshold for
inpatient care, the availability of hospital beds in the
local health area, and co-morbid conditions). This design
is similar to the classic case–control design, with the main
difference that the case and control periods belong to
the same subject, albeit at different times. In a sensitivity
analysis we also performed a conventional nested case–
control study to evaluate the robustness of the results to
the design specifications. A schematic illustration of the
case-crossover design is provided in Figure 1.
Exposure
The primary exposure in this analysis was discharge
from an episode of hospital admission with at least one
full day of stay, regardless of the cause. We further cate-
gorized such admissions to be due to asthma-related
versus non-asthma-related as well as respiratory-related
versus non-respiratory-related. Asthma-related admissions
were those with the most responsible diagnosis being
for asthma (ICD-9 493.xx, ICD-10 J45/J46). Respiratory-
related admissions were those with the most responsible
diagnosis being for a respiratory condition (ICD-9 codes



























































































Figure 1 Schematic illustration of the cohort construction and analysis type. The arrow from left to right represents the timeline of an
individual within the data. The vertical arrow shows an outcome date (admission to hospital due to asthma). The immediate 30-day prior to this
date constitutes the case time window. For each subject, up to two control time windows of the same length were also selected, each 364 days
before and after the start of the case time window. The presence of discharge from a hospitalization in the case and control-time windows
defines the exposure.
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The outcome of interest was a non-elective admission
to hospital with the main diagnosis being asthma (as
described above). A national chart review of the data for
the 2005–2006 fiscal year showed that the main diagnosis
of asthma in a discharge record had a sensitivity of 87%
(95% CI 79%–95%) and a positive predictive value of 90%
(95% CI 85%–95%) [14]. In addition, restricting the study
population to those who satisfied a case definition of
asthma means that the subset of hospitalizations included
in the analysis were even more likely to be truly asthma-
related. In line with the general definition of post-hospital
syndrome, readmissions that counted towards the out-
come did not include elective admissions or emergency
room visits that did not result in inpatient admissions.
Case and control time windows
The 30-day period immediately before each asthma-
related hospitalization was considered as the case time
window (see Figure 1). For each case time window, we
considered up to two control time windows ending
exactly 364 days before and after the index date. The
choice of the timing of control time windows was to
adjust for the effect of seasonality as well as day of the
week as such factors might be potentially correlated
with the risk of hospitalizations. We specifically avoided
using control time windows that are adjacent to case time
windows because first, the individual is protected from
experiencing a hospitalization event in the time period
immediately after the case time window (due to the
length-of-stay of the index hospitalization associated
with the case time window); second, the time adjacent to
the case time window would belong to different month
and potentially season which is an important factor affect-
ing the risk of asthma-related hospitalization.
Eligible control windows were those that fit entirely
within the interval between the entry and exit date of
the individual. Control time windows that did not satisfysuch criteria were removed. Case time windows for which
both control time windows were excluded were also
excluded as they could not contribute to the statistical
inference. Each individual could contribute several cases
and associated control time windows.
Analysis
We calculated the rates of the occurrence of exposure
in both the case and control time windows. In doing
so, and in line with basic principles, we weighted each
control time window according to the reciprocal of the
number of control time windows for the corresponding
case time window [15]. In the main analysis, using condi-
tional logistic regression we calculated the adjusted relative
risk (RR) of the asthma-related hospitalization (outcome)
in association with exposure. We controlled for potentially
time-varying measures of asthma severity (number of
asthma-related admissions, outpatient service use, medi-
cation dispensation, as well the number of dispensed
canisters of short-acting beta-agonists (SABA), inhaled
corticosteroids (ICS), and combined ICS and long-acting
beta-agonists (ICS + LABA)) and general measures of
co-morbidity (Charlson co-morbidity index [16], total
number of admissions, outpatient services use and
medication dispensations), all measured in the 180 days
prior to the (Case and control) time window (Figure 1).
Robust variance estimators were used for inference to
account for within-subject clustering of events (as
outcomes that belong to the same person cannot be
considered as independent observations) [17].
Subgroup, sensitivity, and alternative analyses
Subgroup analysis involved separately performing the
analysis by sex and age groups. We performed several
sensitivity analyses. These included an unadjusted analysis
as well as performing the analysis using a conventional
nested case–control design. The nested case control
design followed the same principles as the main study
Table 1 Characteristics of individuals in the final data set
Number of outcomes per person
Mean (S D) 1.64 (1.81)
[1,2,3,4+] [2804,575,212,261]
Entry time
(In years since 1/1/1997) 1.5 (2.2)
Event time
(In years since 1/1/1997) 5.8 (3.0)
Event time
(Since entry) 4.3 (2.8)
Age at entry date
Mean (SD) 39.4 (14.1)
Age at outcome date
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windows) with the difference being that the control time
windows were selected from other individuals in the
risk set, and no 364-day-interval rule was applied. For a
given case time window, the risk set was defined as
those individuals who were at the risk of experiencing
the outcome (that is, the follow-up day of the index
case they was between the entry and exit date of the
controls) and had the same sex, year of birth, and similar
entry date (within 180 days) as the case. The nested-case
control analysis was further adjusted for all covariates that
were controlled for in the main case-crossover design.
Other sensitivity analyses included choosing control time
windows at different distances from the case time window.
We performed two alternative analyses exploring the
association between discharge from hospital and 60-





Any discharge 687 (10.8%)
Asthma-related discharge 442 (7.0%)
Non-asthma-related discharge 273 (4.3%)
Respiratory-related discharge 523 (8.3%)
Respiratory-related, non-asthma discharge 89 (1.4%)
Non-respiratory-related discharge 189 (3.0%)
*Significant at 0.05 level.
†All RRs are adjusted for the following variables estimated in the 180 days prior to
outpatient services use, medication dispensations, number of dispensations of short-ac
and long-acting beta-agonists, as well as total number of hospital admissions, outpatieto evaluate the potential impact of treatment in the
post-discharge period in the association between the
exposure and outcome, we performed an additional
sensitivity analysis in which the regression model was
further controlled for whether the individual received any
controller medication (systemic corticosteroids, inhaled
corticosteroids with or without long-acting beta-agonists,
or leukotriene receptor antagonists) during the exposure
(case or control) time window.Results
The study cohort constituted 178,192 individuals with
asthma among whom there were 6,333 asthma-related
hospitalizations (outcome) experienced by 3,852 unique
individuals. The associated case time windows for these
events were matched to 10,737 control time windows
(1.70 control time windows per event). Table 1 provides
the basic demographics characteristics of the individuals
in the final analysis.
Results of the conditional logistic regression are provided
in Table 2. In 10.8% of case time windows there was a
discharge from hospital. In comparison, in 7.9% of control
time windows there was a discharge from hospital,
resulting in a RR of asthma-related re-hospitalization
following a hospital admission from any cause of 1.40
(95% CI 1.22 - 1.59), P < 0.001. Nevertheless, such an
increased risk of the outcome was mainly due to the
asthma-related discharge, with an RR of 1.99 (95% CI
1.65 - 2.39). Non-asthma-related discharges were not
associated with 30-day asthma-related readmissions
(RR = 0.88 (95% CI 0.74 - 1.04), P = 0.14). 81% of all
respiratory-related discharges were due to asthma. As
such, and expectedly, they were associated with an
increased risk of the outcome (RR = 1.89 (95% CI 1.60 -
2.22)). Respiratory-related, non-asthma discharges were
not associated with the risk of the outcome (RR = 1.23
(95% CI 0.90 - 1.68), P = 0.20). Non-respiratory-relatedtal) and outcome (asthma-related admission in the
uency Adjusted RR P-value
(95% CI)†Control window
N = 10,737
849 (7.9%) 1.40 (1.22 – 1.59) <0.001*
389 (3.6%) 1.99 (1.65 – 2.39) <0.001*
495 (4.6%) 0.88 (0.74 – 1.04) 0.141
497 (4.6%) 1.89 (1.60 – 2.22) <0.001*
124 (1.2%) 1.23 (0.90 – 1.68) 0.199
381 (3.5%) 0.78 (0.63 – 0.96) 0.017*
the start of the time window: number of asthma-related hospital admissions,
ting beta-agonists, inhaled corticosteroids, and combined inhaled corticosteroids











































Figure 2 Subgroup analysis*. *All RRs are adjusted for the following
variables estimated in the 180 days prior to the start of the time
window: number of asthma-related hospital admissions, outpatient
services use, medication dispensations, number of dispensations of
short-acting beta-agonists, inhaled corticosteroids, and combined
inhaled corticosteroids and long-acting beta-agonists, as well as total
number of hospital admissions, outpatient services use, medication
dispensations, and the Charlson co-morbidity index.
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come (RR = 0.78 (95% CI 0.63 - 0.96)).
Subgroup analyses
Results of the subgroup analysis are provided in Figure 2.
No obvious trend could be observed for the RRs across
sex and age groups, although it appears the RRs for
asthma-related or respiratory-related outcomes were
higher among women than men, whereas the non-
asthma-related and non-respiratory-related RRs were
reciprocally lower among women compared with men.
The negative association between non-respiratory-related
discharges and asthma admissions disappeared in several
subgroups but persisted among women and individuals
35–54 years old.
Sensitivity and alternative analyses
Results of the sensitivity and alternative analyses are pro-
vided in Figure 3. For the most part the overall direction
and significance of the associations remained the same,
with one exception: the negative association between non-
respiratory-related discharges and asthma-related admis-
sions disappeared in all sensitivity and alternative analyses.
Overall, in 31.6% of case time windows and 29.1% of
control time windows a controller medication was dis-
pensed (P < 0.001 for difference). In exposed time windows
(time windows with a hospital discharge), this value was
39.9% (43.9% when the discharge was asthma-related
and 35.7% when it was non-asthma-related, all P < 0.001 for
the difference compared with unexposed time windows).
However, in the sensitivity analysis that was adjusted for
the use of controller medication, the RR of the exposure
only slightly changed compared with the main analysis
[RR = 1.38 (95% CI 1.21 - 1.57)].
Discussion
We used population-based administrative health data
of an entire geographic region to investigate whether
discharge from hospital alters the short-term risk of ad-
mission due to asthma. As expected, we found that
asthma-related and respiratory-related discharges are
significant predictors of asthma-related readmission, but
non-asthma-related discharges were not associated with
the risk of asthma-related readmissions. Other findings of
the study remained the same in several sensitivity analyses.
Our overall conclusion is that non-respiratory-related
Exposure RR (95% CI)*
Any discharge
1.40 (1.22 - 1.59)
1.59 (1.40 - 1.80)
1.20 (1.03 - 1.40)
1.42 (1.27 - 1.57)
1.21 (1.10 - 1.34)
Asthma-related 
discharge 1.99 (1.65 - 2.39)
2.32 (1.95 - 2.77)
1.53 (1.24 - 1.89)
2.01 (1.73 - 2.33)
1.66 (1.46 - 1.90)
Non-asthma-
related discharge 0.88 (0.74 - 1.04)
0.95 (0.81 - 1.11)
0.92 (0.74 - 1.14)
0.94 (0.84 - 1.06)
0.90 (0.80 - 1.01)
Respiratory-related 
discharge 1.89 (1.60 - 2.22)
2.12 (1.82 - 2.48)
1.52 (1.26 - 1.85)
1.83 (1.60 - 2.10)




1.23 (0.90 - 1.68)
1.22 (0.91 - 1.63)
1.46 (0.92 - 2.33)
1.06 (0.84 - 1.33)
1.02 (0.82 - 1.26)
Non-respiratory-
related discharge 0.78 (0.63 - 0.96)
0.86 (0.71 - 1.03)
0.80 (0.63 - 1.03)
0.92 (0.80 - 1.05)
0.88 (0.77 - 1.00)
Figure 3 Results of the sensitivity and subgroup analyses. *All RRs, except for the unadjusted case-cross-over, are adjusted for the following
variables estimated in the 180 days prior to the start of the time window: number of asthma-related hospital admissions, outpatient services use,
medication dispensations, number of dispensations of short-acting beta-agonists, inhaled corticosteroids, and combined inhaled corticosteroids
and long-acting beta-agonists, as well as total number of hospital admissions, outpatient services use, medication dispensations, and the Charlson
co-morbidity index.
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severe asthma exacerbation requiring admission, whereas
an episode of asthma-related discharge is associated with
an elevated rate of readmission. In addition to being a
chance finding, a reduced risk of asthma-related admission
after an episode of non-asthma-related discharge might
indicate that not only the underlying risk of asthma
exacerbation is not affected by an episode of inpatient
care, but such a discharge might result in a higher
threshold for readmitting the patient. In addition, a
period of inpatient care independent of asthma might
prompt a review of asthma management, thus reducing
the risk of asthma exacerbation in the post-discharge
period. Evidence for this pattern was observed in ourdata, as dispensation of controller medications were
more likely to occur in time windows with, compared
with those without, a hospital discharge record.
To our knowledge, the association between discharge
from hospital and the short-term risk of admission due
to asthma has not previously been investigated. Other
investigators have assessed the rate of readmission after
discharge from a previous asthma-related hospitalization,
and factors altering such rates [6,18-21]. But these studies
have not attempted to contrast the risk in the post-
discharge period with control periods, and thus have not
been able to show any change in the risk. In addition,
many of such studies have been based on longer-term
follow-up periods, and the associations reflect the impact
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previous hospitalization [6,18].
In addition to relying on the data of an entire geo-
graphic region that is free from selection bias, the choice
of the case-crossover design gives weight to the validity
of our findings. Many factors, not necessarily captured
in measures of asthma severity and co-morbidity, can
alter the risk of hospitalization for an individual (e.g.,
threshold for hospitalization in the individual’s local
health setting, availability of hospital beds, to name a
few) thus causing a spurious association between the
exposure and outcome. As such, we believe the case-
crossover design, in which such factor are relatively
constant within a patient, is a robust design and the
main results are less affected by such biases than the results
of the nested case control study (although the overall
results were similar).
The limitation of our study should be acknowledged.
The identification of asthma was based on resource use
records. However, the case definition of asthma, used by
several other investigators, in combination with a record
of asthma-related hospitalization, must have created a
very specific sample of asthma patients. Nonetheless, we
acknowledge that the diagnostic accuracy of asthma-
related hospitalization in the extreme of age groups
might not be optimal. Further, the risk of asthma-related
readmissions might well be affected by the cause of the
previous hospitalization. We decided not to subdivide the
exposure any further than asthma-related and respiratory-
related conditions as we were concerned multiple-
comparison issues would make the interpretation of the
results difficult. Additionally, the risk of asthma-related
admission might be a function of events occurring within
the prior hospitalization, such as whether appropriate
care for asthma was provided at discharge, the discharge
medications for asthma, and so on. The observed pattern
of medication dispensation indicated that around the time
of discharge, whether asthma-related or not, patients were
more likely to fill prescriptions for asthma controller
medications, but in the sensitivity analysis that adjusted
for this pattern, no major changes in the findings were
observed. This suggests that dispensation of controller
medications did not play a major role in the observed
findings. Unfortunately, as in many administrative health
databases, medication records during inpatient time were
not captured in our data, and in the 30-day time window
individuals are most likely taking the medications they
received during inpatient time and upon discharge; as
such, dispensation records could not have been reliably
interrogated for such associations.
While we confirmed the previous findings of an
elevated risk of readmission after an asthma-related
hospitalization, our study indicates that the risk of an
asthma-related hospitalization is not increased afterdischarge from non-asthma-related admission. This is
in line with the general belief that the significance of
post-hospital syndrome is primarily related to certain
co-morbidities of chronic diseases in the older population,
and is not a general period of increased risk affecting an
inherently inflammatory condition such as asthma. These
findings can be of relevance from a policy and clinical
perspectives with regard to the managements and recom-
mendations patients with asthma receive upon discharge
from hospital. Lack of association between non-asthma-
related admissions with a subsequent risk of an asthma-
related hospitalizations means in patients with known
asthma who are hospitalized due to non-asthma reasons,
care providers need to focus on other health conditions
that are known to cause readmission. Future research is
required to associate the risk of readmission with such
factors as the level of asthma care during admission,
outpatient care immediately after discharge, and provision
of asthma controller medications in the post-discharge
period as potentially relevant and modifiable factors deter-
mining the risk of asthma-related readmission.
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